Table 1.
Patients’ characteristics.
| Characteristics | Number of patients | nLD (%nuclei) | cLD in NR (%nuclei) |
|---|---|---|---|
| Total patients | 80 | 2.65 | 0.35 |
| Males | 35 | 2.37 | 0.39 |
| Females | 45 | 2.87 | 0.32 |
| Age | |||
| Mean | 58 | ||
| Range | 24–89 | ||
| Liver biopsy proven diagnosis | |||
| Non-alcoholic steatohepatitis | 12 | 2.62 | 0.00 |
| Drug induced liver injury | 11 | 4.48 | 0.45 |
| Autoimmune hepatitis | 7 | 6.09 | 0.90 |
| Primary biliary cholangitis | 1 | 1.54 | 0.00 |
| Alcoholic hepatitis | 1 | 1.48 | 0.74 |
| Simple steatosis | 2 | 1.53 | 0.32 |
| HBV hepatitis | 3 | 2.64 | 0.19 |
| HCV hepatitis | 1 | 3.33 | 0.00 |
| Sarcoidosis | 1 | 0.00 | 0.00 |
| Non-specific hepatitis | 11 | 1.46 | 0.35 |
| Normal liver | 4 | 1.39 | 0.41 |
| Malignant tumors | 22 | 1.96 | 0.44 |
| Other tumors | 4 | 0.00 | 0.00 |
| Liver fibrosis (Metavir) | |||
| F0 | 39 | 1.88 | 0.22 |
| F1 | 26 | 4.21 | 0.58 |
| F2 | 3 | 2.55 | 0.00 |
| F3 | 5 | 1.50 | 0.37 |
| F4 | 0 | – | – |
| Liver steatosis | |||
| < 5% | 46 | 2.77 | 0.46 |
| 5–33% | 21 | 2.83 | 0.19 |
| 33–66% | 4 | 1.63 | 0.00 |
| > 66% | 2 | 1.41 | 0.00 |
HBV hepatitis B virus, HCV hepatitis C virus, nLD nucleoplasmic lipid droplet, cLD in NR cytoplasmic lipid droplet invagination with nucleoplasmic reticulum.